Compare CRISPR conditions with more confidence by verifying Cas9/dCas9 protein abundance before moving to locus-specific readouts.
Explore EpigenTek antibodies and quantitative assay kits: www.epigentek.com/catalog/cris...

Compare CRISPR conditions with more confidence by verifying Cas9/dCas9 protein abundance before moving to locus-specific readouts.
Explore EpigenTek antibodies and quantitative assay kits: www.epigentek.com/catalog/cris...
This study supports the feasibility of using virus-like particle-mediated delivery of #Cas9 ribonucleoprotein to disrupt genes of interest 🧬, enabling a more scalable and cost-effective process for generating T cell #immunotherapies. 🛡️
Learn more: https://bit.ly/4AxvnYg
#ColumbiaUniversity researchers demonstrated that ABE8e-V106W RNP achieves 100% on-target editing in human embryos without #Cas9 -like double-strand breaks, but uncontained off-target editing, bystander mutations, and mosaicism render clinical reproductive use premature. 🧬🤖 #HumanEmbryo #PCSK9
#GEAR26 is almost here! Remember to visit the IDT table to explore our #CRISPR portfolio, including our new #Cas9 mRNA solution and #off-targetanalysis services. Also, check out posters from IDT scientists to see our CRISPR products in action—details below. Learn more here: https://ow.ly/8SXS50ZIiCt